Glomerular podocytes in kidney health and disease

Suheir Assady; Thomas Benzing; Matthias Kretzler; Karl L. Skorecki

doi:10.1016/s0140-6736(18)33000-9

Glomerular podocytes in kidney health and disease

Suheir Assady, Thomas Benzing, Matthias Kretzler, Karl L. Skorecki

Bar-Ilan University - Azrieli Faculty of Medicine

Research output: Contribution to journal › Comment/debate

20 Scopus citations

Original language	English
Pages (from-to)	856-858
Number of pages	3
Journal	The Lancet
Volume	393
Issue number	10174
DOIs	https://doi.org/10.1016/s0140-6736(18)33000-9
State	Published - 2 Mar 2019

Bibliographical note

Funding Information:
SA reports grants from Akebia Therapeutics, GlaxoSmithKline, and KBP Biosciences, outside the submitted work, and is supported by the Chief Scientist Office, Ministry of Health, Israel (grant number 3-00000-9895), and the Harvey and Gloria Kaylie Foundation. MK reports grants from the National Institutes of Health and the University of Michigan during the conduct of the study, grants from Boehringer Ingelheim, Gilead, Lilly, Moderna Therapeutics, Novo Nordisk, Janssen, and AstraZeneca, outside the area of work commented on here, and gifts in support of NEPTUNE from Nephcure Kidney International and Retrophin. KLS reports personal fees from Elsevier, outside the submitted work, and receives support from the Israel Science Foundation (grant number 182/15), the Ernest and Bonnie Beutler Family Foundation, and the Harvey and Gloria Kaylie Foundation. TB declares no competing interests.

Funding

SA reports grants from Akebia Therapeutics, GlaxoSmithKline, and KBP Biosciences, outside the submitted work, and is supported by the Chief Scientist Office, Ministry of Health, Israel (grant number 3-00000-9895), and the Harvey and Gloria Kaylie Foundation. MK reports grants from the National Institutes of Health and the University of Michigan during the conduct of the study, grants from Boehringer Ingelheim, Gilead, Lilly, Moderna Therapeutics, Novo Nordisk, Janssen, and AstraZeneca, outside the area of work commented on here, and gifts in support of NEPTUNE from Nephcure Kidney International and Retrophin. KLS reports personal fees from Elsevier, outside the submitted work, and receives support from the Israel Science Foundation (grant number 182/15), the Ernest and Bonnie Beutler Family Foundation, and the Harvey and Gloria Kaylie Foundation. TB declares no competing interests.

Funders	Funder number
Israel Science Foundation	182/15

Access to Document

10.1016/s0140-6736(18)33000-9

Cite this

@article{6ba44cb03a0a4926af1c1b1645d3e4cc,

title = "Glomerular podocytes in kidney health and disease",

author = "Suheir Assady and Thomas Benzing and Matthias Kretzler and Skorecki, {Karl L.}",

note = "Funding Information: SA reports grants from Akebia Therapeutics, GlaxoSmithKline, and KBP Biosciences, outside the submitted work, and is supported by the Chief Scientist Office, Ministry of Health, Israel (grant number 3-00000-9895), and the Harvey and Gloria Kaylie Foundation. MK reports grants from the National Institutes of Health and the University of Michigan during the conduct of the study, grants from Boehringer Ingelheim, Gilead, Lilly, Moderna Therapeutics, Novo Nordisk, Janssen, and AstraZeneca, outside the area of work commented on here, and gifts in support of NEPTUNE from Nephcure Kidney International and Retrophin. KLS reports personal fees from Elsevier, outside the submitted work, and receives support from the Israel Science Foundation (grant number 182/15), the Ernest and Bonnie Beutler Family Foundation, and the Harvey and Gloria Kaylie Foundation. TB declares no competing interests.",

year = "2019",

month = mar,

day = "2",

doi = "10.1016/s0140-6736(18)33000-9",

language = "אנגלית",

volume = "393",

pages = "856--858",

journal = "The Lancet",

issn = "0140-6736",

publisher = "Elsevier Ltd.",

number = "10174",

}

TY - JOUR

T1 - Glomerular podocytes in kidney health and disease

AU - Assady, Suheir

AU - Benzing, Thomas

AU - Kretzler, Matthias

AU - Skorecki, Karl L.

N1 - Funding Information: SA reports grants from Akebia Therapeutics, GlaxoSmithKline, and KBP Biosciences, outside the submitted work, and is supported by the Chief Scientist Office, Ministry of Health, Israel (grant number 3-00000-9895), and the Harvey and Gloria Kaylie Foundation. MK reports grants from the National Institutes of Health and the University of Michigan during the conduct of the study, grants from Boehringer Ingelheim, Gilead, Lilly, Moderna Therapeutics, Novo Nordisk, Janssen, and AstraZeneca, outside the area of work commented on here, and gifts in support of NEPTUNE from Nephcure Kidney International and Retrophin. KLS reports personal fees from Elsevier, outside the submitted work, and receives support from the Israel Science Foundation (grant number 182/15), the Ernest and Bonnie Beutler Family Foundation, and the Harvey and Gloria Kaylie Foundation. TB declares no competing interests.

PY - 2019/3/2

Y1 - 2019/3/2

UR - http://www.scopus.com/inward/record.url?scp=85062151136&partnerID=8YFLogxK

U2 - 10.1016/s0140-6736(18)33000-9

DO - 10.1016/s0140-6736(18)33000-9

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.comment???

C2 - 30837131

AN - SCOPUS:85062151136

SN - 0140-6736

VL - 393

SP - 856

EP - 858

JO - The Lancet

JF - The Lancet

IS - 10174

ER -

Glomerular podocytes in kidney health and disease

Bibliographical note

Funding

Access to Document

Other files and links

Cite this